D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 116 Citations 49,252 365 World Ranking 147 National Ranking 98
Medicine D-index 121 Citations 51,425 413 World Ranking 1494 National Ranking 900

Overview

What is he best known for?

The fields of study he is best known for:

  • Immune system
  • Gene
  • Cancer

The scientist’s investigation covers issues in Immunology, Immunotherapy, Cytotoxic T cell, Antigen and Epstein–Barr virus. The study incorporates disciplines such as Hematopoietic stem cell transplantation, Transplantation and Virology in addition to Immunology. His Immunotherapy study is related to the wider topic of Immune system.

His Cytotoxic T cell research is multidisciplinary, incorporating elements of T cell, Cancer research and T lymphocyte. Cliona M. Rooney interconnects Tumor microenvironment, Molecular biology and Chimeric antigen receptor in the investigation of issues within Antigen. Cliona M. Rooney has included themes like Herpesviridae and Lymphoma in his Epstein–Barr virus study.

His most cited work include:

  • Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. (1058 citations)
  • Infusion of Cytotoxic T Cells for the Prevention and Treatment of Epstein-Barr Virus–Induced Lymphoma in Allogeneic Transplant Recipients (1030 citations)
  • Inducible apoptosis as a safety switch for adoptive cell therapy (993 citations)

What are the main themes of his work throughout his whole career to date?

Cliona M. Rooney spends much of his time researching Immunology, Cytotoxic T cell, Antigen, Immunotherapy and T cell. His research links Virology with Immunology. His Cytotoxic T cell study combines topics in areas such as Molecular biology and Transplantation.

His studies in Antigen integrate themes in fields like Cancer research and Chimeric antigen receptor. In his work, Hematopoietic stem cell and Lymphoproliferative disorders is strongly intertwined with Hematopoietic stem cell transplantation, which is a subfield of Immunotherapy. Cliona M. Rooney combines subjects such as Human leukocyte antigen and Cell biology with his study of T cell.

He most often published in these fields:

  • Immunology (74.91%)
  • Cytotoxic T cell (51.60%)
  • Antigen (41.81%)

What were the highlights of his more recent work (between 2014-2021)?

  • Immunology (74.91%)
  • Antigen (41.81%)
  • T cell (29.36%)

In recent papers he was focusing on the following fields of study:

Cliona M. Rooney focuses on Immunology, Antigen, T cell, Cancer research and Immunotherapy. The various areas that Cliona M. Rooney examines in his Immunology study include Cytotoxic T cell and Hematopoietic stem cell transplantation, Transplantation. Cliona M. Rooney has researched Antigen in several fields, including Tumor microenvironment, Immune system and Chimeric antigen receptor.

His T cell study combines topics from a wide range of disciplines, such as Molecular biology, Viral vector, In vivo and Virology. His research in Cancer research intersects with topics in Car t cells, B cell and CD19. His work carried out in the field of Immunotherapy brings together such families of science as Receptor and Cytokine.

Between 2014 and 2021, his most popular works were:

  • Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma (500 citations)
  • HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial (249 citations)
  • Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation (177 citations)

In his most recent research, the most cited papers focused on:

  • Immune system
  • Gene
  • Cancer

His primary scientific interests are in Immunology, Antigen, Chimeric antigen receptor, Immunotherapy and T cell. His biological study spans a wide range of topics, including Cytotoxic T cell, Transplantation and Virology. He is interested in Antigen-presenting cell, which is a branch of Cytotoxic T cell.

Cliona M. Rooney has researched Antigen in several fields, including Tumor microenvironment, Immune system, Receptor and Cancer research. His research in Immunotherapy intersects with topics in Cell culture, K562 cells, Lymphoma, Interleukin and In vivo. His studies deal with areas such as Inhibitory postsynaptic potential, Viral vector, Long terminal repeat and Cell biology as well as T cell.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation.

C.M Rooney;C.Y.C Ng;S Loftin;C.A Smith.
The Lancet (1995)

1279 Citations

Infusion of Cytotoxic T Cells for the Prevention and Treatment of Epstein-Barr Virus–Induced Lymphoma in Allogeneic Transplant Recipients

Cliona M. Rooney;Colton A. Smith;Colton A. Smith;Catherine Y.C. Ng;Catherine Y.C. Ng;Susan K. Loftin;Susan K. Loftin.
Blood (1998)

1279 Citations

Inducible apoptosis as a safety switch for adoptive cell therapy

Antonio Di Stasi;Siok Keen Tey;Gianpietro Dotti;Yuriko Fujita.
The New England Journal of Medicine (2011)

1233 Citations

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

Martin A. Pule;Barbara Savoldo;G. Doug Myers;G. Doug Myers;Claudia Rossig.
Nature Medicine (2008)

1149 Citations

CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients

Barbara Savoldo;Carlos Almeida Ramos;Carlos Almeida Ramos;Enli Liu;Martha P. Mims.
Journal of Clinical Investigation (2011)

971 Citations

Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma

Chrystal U. Louis;Chrystal U. Louis;Barbara Savoldo;Barbara Savoldo;Gianpietro Dotti;Gianpietro Dotti;Martin Pule.
Blood (2011)

960 Citations

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

Helen E. Heslop;Catherine Y.C. Ng;Congfen Li;Colton A. Smith.
Nature Medicine (1996)

959 Citations

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

Helen E. Heslop;Karen S. Slobod;Martin A. Pule;Gregory A. Hale.
Blood (2010)

748 Citations

Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

Nabil Ahmed;Vita S. Brawley;Meenakshi Hegde;Catherine Robertson.
Journal of Clinical Oncology (2015)

670 Citations

Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer

Jeong Heo;Tony Reid;Leyo Ruo;Caroline J. Breitbach.
Nature Medicine (2013)

650 Citations

Best Scientists Citing Cliona M. Rooney

Malcolm K. Brenner

Malcolm K. Brenner

Baylor College of Medicine

Publications: 159

Catherine M. Bollard

Catherine M. Bollard

George Washington University

Publications: 152

Carl H. June

Carl H. June

University of Pennsylvania

Publications: 146

Helen E. Heslop

Helen E. Heslop

Baylor College of Medicine

Publications: 133

Gianpietro Dotti

Gianpietro Dotti

University of North Carolina at Chapel Hill

Publications: 123

Stanley R. Riddell

Stanley R. Riddell

Fred Hutchinson Cancer Research Center

Publications: 113

Alan B. Rickinson

Alan B. Rickinson

University of Birmingham

Publications: 111

Laurence J.N. Cooper

Laurence J.N. Cooper

The University of Texas MD Anderson Cancer Center

Publications: 100

Rajiv Khanna

Rajiv Khanna

QIMR Berghofer Medical Research Institute

Publications: 97

Steven A. Rosenberg

Steven A. Rosenberg

National Institutes of Health

Publications: 84

Michel Sadelain

Michel Sadelain

Memorial Sloan Kettering Cancer Center

Publications: 78

Michael C. Jensen

Michael C. Jensen

Seattle Children's Hospital

Publications: 69

Phillip K. Darcy

Phillip K. Darcy

Peter MacCallum Cancer Centre

Publications: 66

Franco Locatelli

Franco Locatelli

Bambino Gesù Children's Hospital

Publications: 66

Stephen Gottschalk

Stephen Gottschalk

St. Jude Children's Research Hospital

Publications: 65

Christian Münz

Christian Münz

University of Zurich

Publications: 65

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us
Something went wrong. Please try again later.